Question 1

What is the PE ratio of REGN?

Accepted Answer

The trailing twelve-month PE ratio of REGN reflects how much investors pay per dollar of Regeneron Pharmaceuticals, Inc.'s earnings. This metric is most useful when compared to Biotechnology peers and the company's own historical range.

Question 2

Is REGN overvalued based on PE ratio?

Accepted Answer

Whether REGN is overvalued depends on comparing its PE ratio to Biotechnology peers, historical averages, and growth expectations. A PE above the sector average may indicate overvaluation, but high-growth companies often command premium multiples. Consider pairing PE analysis with a DCF model for a more complete picture.

Question 3

How do I value REGN stock using PE ratio?

Accepted Answer

To value Regeneron Pharmaceuticals, Inc. using PE: (1) Compare the current PE against the Biotechnology median to assess relative pricing, (2) check the PEG ratio to adjust for growth expectations, (3) review the 5-year PE range to identify where the stock sits historically, and (4) estimate fair value by multiplying a target PE by forward EPS estimates. This relative approach complements DCF's absolute valuation.

Question 4

What is the PEG ratio of REGN?

Accepted Answer

The PEG ratio divides the PE ratio by the expected earnings growth rate, providing a growth-adjusted valuation metric. A PEG below 1.0 may indicate undervaluation relative to growth, while above 2.0 may suggest overvaluation. PEG is most reliable for companies with stable, predictable earnings growth.

Question 5

Should I use PE ratio or DCF for REGN stock valuation?

Accepted Answer

PE ratio gives a quick relative read — how REGN is priced versus Biotechnology peers. DCF provides an absolute value based on projected free cash flows. For the most reliable valuation, use PE as a quick comparability screen and DCF for a deeper fundamental analysis. Each method has blind spots: PE ignores capital structure and cash flow quality, while DCF is sensitive to growth and discount rate assumptions.

Regeneron Pharmaceuticals, Inc. (REGN) PE 估值

使用 PE 市盈率计算 REGN 公允价值

公司简介

财务指标 — REGN PE 估值数据

常见问题

REGN 的市盈率是多少？

基于市盈率，REGN 被高估了吗？

如何使用市盈率对 REGN 进行估值？

REGN 的 PEG 比率是多少？

对 REGN 应该使用 PE 还是 DCF 估值？

了解更多

相关 PE 估值